1Yang L,Yang G,Zhou M,et al.Body mass index and mortality from lung cancer in smokers and nonsmokers:A nationally representative prospective study of 220,000 men in China[J].Int J Cancer,2009,125 (9):2136-2143.
2Tan S,Sun C,Wei X,et al.Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood[J].Exp Lung Res,2013,39(4-5):182-190.
3Van der Drift MA,Hol BE,Klaassen CH,et al.Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer[J].Lung Cancer,2010,68 (2):283-287.
4Sirera R,Bremnes RM,Cabrera A,et al.Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer[J].J Thorac Oncol,2011,6 (2):286-290.
7Eberhard DA,Giaccone G,Johnson BE,et al.Biomarkers of response to epidermal growth factor receptor inhibitors in non-small-cell lung cancer working group:Standardization for use in the clinical trial setting[J].Clin Oncol,2008,26 (6):983-994.
8Li J,Hu YM,Wang Y,et al.Gene mutation analysis in non-small cell lung cancer using bronchoalveolar lavage fluid and tumor tissue as diagnostic markers.[J].lnt J Biol Markers,2014,1:31.
9Jiang C,Hu X,Alattar M,et al.miRNA expression profiles associated with diagnosis and prognosis in lung cancer[J].Expert Rev Anticancer Ther,2014,14 (4):453-461.
10Chen X,Hu Z,Wang W,et al.Identification of ten serum microRNAs from a genome-wide serum microRNA expression pro-file as novel noninvasive biomarkers for non small cell lung cancer diagnosis[J].Int J Cancer,2012,130(7):1620-1628.
